Andere Kunden interessierten sich auch für
![Piperazine: A Biologically Active Scaffold]( "Piperazine: A Biologically Active Scaffold")
Piperazine: A Biologically Active Scaffold50,99 €![Development of New Synthetic Methodologies by Heterogeneous Catalysts]( "Development of New Synthetic Methodologies by Heterogeneous Catalysts")
Development of New Synthetic Methodologies by Heterogeneous Catalysts40,99 €![Quinazoline: Privileged Nature as Effective Pharmacological Agents]( "Quinazoline: Privileged Nature as Effective Pharmacological Agents")
Quinazoline: Privileged Nature as Effective Pharmacological Agents26,99 €![Polyester scaffold by radiation grafting for tissue engineering]( "Polyester scaffold by radiation grafting for tissue engineering")
Polyester scaffold by radiation grafting for tissue engineering51,99 €![Synthesis of Biologically Active Carbazoles]( "Synthesis of Biologically Active Carbazoles")
Synthesis of Biologically Active Carbazoles51,99 €![Biologically Active Nitrogen and Oxygen Containing Heterocycles]( "Biologically Active Nitrogen and Oxygen Containing Heterocycles")
Biologically Active Nitrogen and Oxygen Containing Heterocycles48,99 €![Amino Acid based Biologically Active Compounds]( "Amino Acid based Biologically Active Compounds")
Amino Acid based Biologically Active Compounds23,99 €
Privileged structures are molecular scaffolds with versatile binding properties, such that a single scaffold is able to provide potent and selective ligands for a range of different biological targets through the simple manipulation of the functional groups. In addition, privileged structures typically exhibit good drug-like properties, which in turn leads to more drug-like compound libraries and leads. In this book the possibility to develop a versatile methodology for the syntheis of biologically relevant privileged scaffolds is deeply explored. The first part of the book is focused on the development of a multicomponent approach for the synthesis of Dihydropirans and Sugars. The second part of the book is focused on the synthesis and the biological evaluation, against HIV virus, of derivatives with a rhodaninc structure. Finally, the third part regards the attemps to synthesize the indenic privileged structure as a strategy to obtain the natural product Cyanosporoside.